Performance of glucagon stimulation test in diagnosing central adrenal insufficiency in children when utilising the Roche Elecsys® cortisol II assay: a pilot study
- 9 August 2022
- journal article
- research article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 35 (10) , 1272-1277
Abstract
Objectives: The glucagon stimulation test (GST) is used for the simultaneous assessment of central adrenal insufficiency (CAI) and growth hormone deficiency. The new Roche cortisol II (C II) assay was recently introduced, confounding interpretation of the GST. The performance of the GST in diagnosing central adrenal insufficiency (CAI), utilising the C II assay, was therefore compared with that of the overnight metyrapone test (ONMTPT). Methods: A diagnostic accuracy study was performed by retrospectively analysing folders and laboratory records of 25 children and adolescents investigated for hypopituitarism with the GST and the ONMTPT between September 2016 and December 2019. The peak serum cortisol (C) of the GST, the post-metyrapone serum 11-deoxycortisol and adrenocorticotropin levels of the ONMTPT were recorded. Diagnostic performance of the GST at a previously suggested cut-off of 374 nmol/L was evaluated. Results: Seventeen boys and 8 girls, aged 1.7–16.3 years (median 7.3 years) were identified. The sensitivity of the post-GST C-level at 374 nmol/L was 0.40 (95% confidence interval [CI] 0.17–0.69), specificity 0.64 (95% CI 0.39–0.84), positive predictive value 0.44 (95% CI 0.19–0.73), negative predictive value 0.60 (95% CI 0.36–0.80), accuracy 0.54 (95% CI 0.35–0.72), positive likelihood ratio (+LR) 0.93 (95% CI 0.49–1.77) and negative LR 1.12 (95% CI 0.40–3.15). The area under the receiver of operating characteristics (ROC) curve was 0.379 (95% CI 0.142–0.615). Conclusions: This study suggests that the GST at any C II cut-off cannot replace the ONMTPT as a diagnostic test for CAI in children. Findings should be confirmed in a larger study.Keywords
This publication has 20 references indexed in Scilit:
- Revised GH and cortisol cut-points for the glucagon stimulation test in the evaluation of GH and hypothalamic–pituitary–adrenal axes in adults: results from a prospective randomized multicenter studyPituitary, 2016
- Hypothalamic-Pituitary-Adrenal Axis Suppression in Asthmatic School ChildrenPediatrics, 2012
- Comparison of the overnight metyrapone and glucagon stimulation tests in the assessment of secondary hypoadrenalismClinical Endocrinology, 2012
- Quantifying the risk of hypoglycaemia in children undergoing the glucagon stimulation testClinical Endocrinology, 2011
- Assessing the Function of the Human Adrenal Cortex2011
- The Accuracy of the Glucagon Test Compared to the Insulin Tolerance Test in the Diagnosis of Adrenal Insufficiency in Young Children with Growth Hormone DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2010
- Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgeryEuropean Journal of Endocrinology, 2010
- Hypothalamic‐pituitary‐adrenal axis suppression in asthmatic children on inhaled corticosteroids: Part 1. Which test should be used?Pediatric Allergy and Immunology, 2007
- COMPARISON OF THE ACTH AND CORTISOL RESPONSES TO PROVOCATIVE TESTING WITH GLUCAGON AND INSULIN HYPOGLYCAEMIA IN NORMAL SUBJECTSClinical Endocrinology, 1989
- THE SHORT METYRAPONE TEST: COMPARISON OF THE PLASMA ACTH RESPONSE TO METYRAPONE AND INSULIN‐INDUCED HYPOGLYCAEMIAClinical Endocrinology, 1979